These include, extreme tiredness, a lack of energy, pins and needles, muscle weakness, disturbed vision, mouth ulcers, a sore and red tongue, and cognitive or psychological concerns such as depression, confusion, and difficulty with memory, understanding or judgement
2012:Appendix A
Cysteine metabolic dysregulation could lead to diminished GSH and MT production, intensifying oxidative stress, damaging hair follicles, and potentially causing hair loss
Figure 2: Structural formula of Liraglutide Figure 3: DPP-4 cleavage site on GLP-1 Liraglutides design achieved two breakthroughs: 1
Previous research has shown that immuno-metabolic dysregulations map more consistently to symptoms of the atypical spectrum characterized by altered energy intake/output (in particular the reversed neurovegetative symptoms of hyperphagia, hypersomnia with leaden paralysis and fatigue) [2] and symptoms of anhedonia [33]
Studies using FDA adverse event data found elevated reporting odds ratios for alopecia with semaglutide at 2.46 and tirzepatide at 1.73